Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Lorusso

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|February 24, 2001
Oxaliplatin in tumors other than colorectal cancerP M Lorusso
Journal of Cellular Biochemistry|August 24, 2006
Vascular disrupting agentsM J Pilat, P M Lorusso
British Journal of Cancer|July 9, 2004
Targeting the epidermal growth factor receptorB F El-Rayes, P M LoRusso
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
BET inhibitors: a novel epigenetic approachD B Doroshow, J P Eder, P M LoRusso
The Journal of Ambulatory Care Management|January 10, 1985
A computer-based emergency unit management system for a multi-institutional systemP M LoRusso, R S Alexander, M H Goldsmith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.
Investigational New Drugs|January 1, 1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)B J Foster, L Jones, R Wiegand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Cytotoxic chemotherapy regimens that increase dose per cycle (dose intensity) by extending daily dosing from 5 consecutive days to 28 consecutive days and beyondK A Keyes, B Albella, P M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Phase II study of CI-958 in colorectal cancerA F Shields, P A Philip, P M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activityB J Foster, R A Wiegand, S Pugh, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|February 24, 2001
Oxaliplatin in tumors other than colorectal cancerP M Lorusso
Journal of Cellular Biochemistry|August 24, 2006
Vascular disrupting agentsM J Pilat, P M Lorusso
British Journal of Cancer|July 9, 2004
Targeting the epidermal growth factor receptorB F El-Rayes, P M LoRusso
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
BET inhibitors: a novel epigenetic approachD B Doroshow, J P Eder, P M LoRusso
The Journal of Ambulatory Care Management|January 10, 1985
A computer-based emergency unit management system for a multi-institutional systemP M LoRusso, R S Alexander, M H Goldsmith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.
Investigational New Drugs|January 1, 1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)B J Foster, L Jones, R Wiegand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Cytotoxic chemotherapy regimens that increase dose per cycle (dose intensity) by extending daily dosing from 5 consecutive days to 28 consecutive days and beyondK A Keyes, B Albella, P M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Phase II study of CI-958 in colorectal cancerA F Shields, P A Philip, P M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activityB J Foster, R A Wiegand, S Pugh, et al.
Pageof 3